Former DOJ officials suggest antitrust attention, action to address concerning traits of health care conglomerates

For the past decade, antitrust enforcement and policy have highlighted the growing size and power of big tech platforms. In a new opinion piece, two experts who worked in the U.S. Department of Justice’s antitrust division argue that a few huge health care conglomerate platforms have many of the same concerning traits as big tech platforms. In suggesting that policymakers and stakeholders look beyond the individual services provided by each platform, they recommend that antitrust attention and action may be needed.